AGC
SGFY

Angelo Gordon & Co’s Signify Health, Inc. SGFY Stock Holding History

Angelo Gordon & Co’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-210,400
Closed -$6.03M – 209
2022
Q4 		$6.03M Buy
210,400
+110,400
+110% +$3.19M 1.11% 14
2022
Q3 		$2.92M Buy
+100,000
New +$2.3M 0.53% 35

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $13.5B AUM 44.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Angelo Gordon & Co's SGFY Position: Q1 2023 in Review

Angelo Gordon & Co sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 210,400 shares — an estimated $6.03M sold.

Angelo Gordon & Co first reported a position in SGFY in Q3 2022 and held it in 2 quarters. The position peaked at $6.03M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Angelo Gordon & Co reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Angelo Gordon & Co sold 210,400 Signify Health, Inc. shares in Q1 2023, an estimated $6.03M.
  • Angelo Gordon & Co first reported a position in Signify Health, Inc. in Q3 2022 and held it in 2 quarters.
  • Angelo Gordon & Co's Signify Health, Inc. position peaked at $6.03M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.